Save time and get answers to complex questions with AI chat
Mobic injection patent oehringer ingelheim france?Dabrafenib and trametinib price?Stribild expiry date?Quartette side effects?Dabrafenib mesylate when the patent is expiring in india?
See the DrugPatentWatch profile for Rhopressa
Rhopressa (netarsudil ophthalmic solution) was FDA-approved in December 2017.
Rhopressa is used to lower intraocular pressure in patients with glaucoma or ocular hypertension.
[1] https://www.drugpatentwatch.com/
Other Questions About Rhopressa :